By Market Intelligence Team

OPEN MINDS, The Behavioral Health & Social Service Industry Analyst Industry News Between 1993 and 2003, the use of medications to treat attention deficit/hyperactivity disorder (ADHD) grew by 274% among children between the ages of five and 19. Global spending on ADHD medications rose from less than $300 million in 1993 to $2.4 billion in 2003 adjusted for inflation. Spending grew by 41% per year between 2000 and 2003. The average spending growth rate was 18% per year over the 10-year term. The United States accounted for over . . .
Restricted Content

You must be a member to view this resource.

Log in | Sign up or learn more about membership options
OPEN MINDS, The Behavioral Health & Social Service Industry Analyst Industry News Between 1993 and 2003, the use of medications to treat attention deficit/hyperactivity disorder (ADHD) grew by 274% among children between the ages of five and 19. Global spending on ADHD medications rose from less than $300 million in 1993 to $2.4 billion in 2003 adjusted for inflation. Spending grew by 41% per year between 2000 and 2003. The average spending growth rate was 18% per year over the 10-year term. The United States accounted for over . . .
Restricted Content

You must be a member to view this resource.

Log in | Sign up or learn more about membership options

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!